# Ganga Pharmaceuticals Ltd (GANGAPHARM)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹12
Day Change: +0%
52W High: ₹14.8
52W Low: ₹9.35
Market Cap: ₹7 Cr

## Valuation
P/E: 109.09
P/B: 0.9
EPS: ₹0.11
Book Value: ₹13.36
Dividend Yield: 0%

## Returns
1Y Return: -11.18%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Ganga Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Ganga Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

## Data Freshness
Quote Updated: 2026-05-21T07:45:19.611Z
Price History Updated: 2026-05-21T07:45:20.495Z
Latest Price History Date: 2026-05-21
Technicals Updated: 2026-05-21T07:45:20.495Z
Quant Updated: 2026-05-21T07:45:20.495Z
Sentiment Updated: 2026-05-21T07:45:20.495Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2021)
Revenue: ₹3.08 Cr
Operating Profit: ₹0.38 Cr (OPM 12.34%)
Net Profit: ₹0.19 Cr
Tax: ₹0.26 Cr

## Balance Sheet (Mar 2021)
Total Assets: ₹7.57 Cr
Total Liabilities: ₹7.57 Cr
Borrowings: ₹1.45 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/gangapharm
Disclaimer: For research and education only. Not investment advice.